Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A New Standard of Care for Appendiceal Mucinous Tumors with Peritoneal Dissemination

 

 Buy Article Permissions and Reprints

ABSTRACT

In the past, mucinous appendiceal tumors and the pseudomyxoma peritonei syndrome were treated with serial debulking procedures. Some benefit was achieved, but no long-term survivals were seen. A new standard of care that involves the complete removal of all visible disease using peritonectomy procedures combined with intraperitoneal chemotherapy washing has developed. This new approach is jeopardized when extensive prior surgical procedures have violated the peritoneum as a first line of defense of the host against carcinomatosis. In patients who have a complete cytoreduction, a 5-year survival of 80% is expected. In patients who have an incomplete cytoreduction, no 10-year survivors are seen. These studies suggest a new standard of care for appendiceal mucinous tumors with peritoneal dissemination.

REFERENCES

• 1 Mahteme H, Sugarbaker P H. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.  Br J Surg. 2004;  91 1168-1173
  CrossrefPubMedGoogle Scholar
• 2 Sugarbaker P H, Ronnett B M, Archer A et al.. Pseudomyxoma peritonei syndrome.  Adv Surg. 1997;  30 233-280
  PubMedGoogle Scholar
• 3 Higa E, Rosai J, Pizzimbono C A, Wise L. Mucosal hyperplasia, mucinous cystadenoma and mucinous cystadenocarcinoma of the appendix.  Cancer. 1973;  32 1525-1541
  CrossrefPubMedGoogle Scholar
• 4 Ronnett B M, Shmookler B M, Sugarbaker P H, Kurman R J. Pseudomyxoma Peritonei: New Concepts in Diagnosis, Origin, Nomenclature, and Relationship to Mucinous Borderline (Low Malignant Potential) Tumors of the Ovary. Anatomic Pathology Chicago; ASCP Press 1997: 197-226
  Google Scholar
• 5 Sugarbaker P H. Pseudomyxoma peritonei: a cancer whose biology is characterized by a redistribution phenomenon.  Ann Surg. 1994;  219 109-111
  CrossrefPubMedGoogle Scholar
• 6 Sugarbaker P H. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH Peritoneal Carcinomatosis: Principles of Management Boston; Kluwer 1996: 79-100
  Google Scholar
• 7 Gonzalez-Moreno S, Brun E, Sugarbaker P H. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.  Ann Surg Oncol. 2005;  12 72-80
  CrossrefPubMedGoogle Scholar
• 8 Yan H, Pestieau S R, Shmookler B M, Sugarbaker P H. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure vs. success with a second-look operation.  Mod Pathol. 2001;  14 164-171
  CrossrefPubMedGoogle Scholar
• 9 Ronnett B M, Yan H, Kurman R J, Shmookler B M, Wu L, Sugarbaker P H. Pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis has a significantly more favorable prognosis than peritoneal mucinous carcinomatosis.  Cancer. 2001;  92 85-91
  CrossrefPubMedGoogle Scholar
• 10 Lyss A P. Appendiceal malignancies.  Semin Oncol. 1988;  15 129-137
  PubMedGoogle Scholar
• 11 Esquivel J, Sugarbaker P H. Clinical presentation of the pseudomyxoma peritonei syndrome.  Br J Surg. 2000;  87 1414-1418
  CrossrefPubMedGoogle Scholar
• 12 Jacquet P, Averbach A M, Stephens A D, Sugarbaker P H. Cancer recurrence following laparoscopic colectomy: report of two patients treated with heated intraoperative chemotherapy.  Dis Colon Rectum. 1995;  38 1110-1114
  PubMedGoogle Scholar
• 13 Misdraji J, Yantiss R K, Graeme-Cook F M, Balis U J, Young R H. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.  Am J Surg Pathol. 2003;  27 1089-1103
  CrossrefPubMedGoogle Scholar
• 14 Hesketh K T. The management of primary adenocarcinoma of the vermiform appendix.  Gut. 1963;  4 158-168
  PubMedGoogle Scholar
• 15 Sugarbaker P H. Intraperitoneal Chemotherapy and Cytoreductive Surgery: A Manual for Physicians and Nurses. 3rd ed. Grand Rapids, MI; Ludann 1999
  Google Scholar
• 16 Sugarbaker P H. Peritonectomy procedures.  Ann Surg. 1995;  221 29-42
  CrossrefPubMedGoogle Scholar
• 17 Stephens A D, Alderman R, Chang D et al.. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique.  Ann Surg Oncol. 1999;  6 790-796
  CrossrefPubMedGoogle Scholar
• 18 Sugarbaker P H. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.  Ann Surg Oncol. 1999;  6 727-731
  CrossrefPubMedGoogle Scholar
• 19 Jacquet P, Sugarbaker P H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis.  J Exp Clin Cancer Res. 1996;  15 49-58
  PubMedGoogle Scholar

Paul H SugarbakerM.D. 

Washington Cancer Institute, 106 Irving St., NW, Ste.

3900, Washington, DC 20010-2975

Email: Paul.Sugarbaker@medstar.net